​

LifeStance Health Group (LFST) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LFST Stock Forecast

LifeStance Health Group (LFST) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $13.57, with a high of $19.00 and a low of $9.00. This represents a 6.02% increase from the last price of $12.80.

- $4 $8 $12 $16 $20 High: $19 Avg: $13.57 Low: $9 Last Closed Price: $12.8

LFST Stock Rating

LifeStance Health Group stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (81.82%), 2 Hold (18.18%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 2 9 Strong Sell Sell Hold Buy Strong Buy

LFST Price Target Upside V Benchmarks

TypeNameUpside
StockLifeStance Health Group6.02%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks17.57%

Price Target Trends

1M3M12M
# Anlaysts2917
Avg Price Target$17.00$14.44$12.15
Last Closing Price$12.80$12.80$12.80
Upside/Downside32.81%12.81%-5.08%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26272--11
Aug, 26272--11
Jul, 26272--11
Jun, 26271--10
May, 26271--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 09, 2026Richard CloseCanaccord Genuity$15.00$12.8017.19%17.19%
Aug 19, 2026BTIG$19.00$12.5651.27%48.44%
Aug 07, 2026Morgan Stanley$13.00$10.7720.71%1.56%
Aug 07, 2026BMO Capital$13.00$10.6621.95%1.56%
Aug 07, 2026BTIG$16.00$10.6650.09%25.00%
Jul 24, 2026BTIG$15.00$10.8138.76%17.19%
Jul 21, 2026Canaccord Genuity$13.00$11.3414.64%1.56%
Jul 14, 2026Barclays$13.00$10.8819.49%1.56%
Jul 13, 2026Steve DechertKeyBanc$13.00$10.7121.38%1.56%
Jun 05, 2026Scott FidelGoldman Sachs$9.00$7.6417.80%-29.69%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 19, 2026BTIGBuyBuyhold
Aug 07, 2026Morgan StanleyOverweightOverweighthold
Aug 07, 2026BMO CapitalOutperformOutperformhold
Jul 24, 2026BTIGBuyBuyhold
Jul 14, 2026BarclaysOverweightOverweighthold
Jul 13, 2026KeyBancOverweightOverweighthold
Jun 05, 2026Goldman SachsBuyNeutralinitialise
Feb 25, 2026BMO CapitalOutperformOutperformhold
Feb 02, 2026BTIGBuyBuyhold
Jan 08, 2026KeyBancOverweightOverweighthold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-1.05$-0.61$-0.51$-0.15$0.03-
Avg Forecast$-0.87$-0.61$-0.48$-0.17$-0.13$-0.02
High Forecast$-0.85$-0.60$-0.46$-0.16$-0.08$0.01
Low Forecast$-0.89$-0.61$-0.49$-0.17$-0.18$-0.05
Surprise %20.69%-6.25%-11.76%-123.08%-

Revenue Forecast

$650M $840M $1B $1B $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$667.51M$859.54M$1.06B$1.25B$1.42B-
Avg Forecast$668.47M$846.42M$1.04B$1.24B$1.39B$1.58B
High Forecast$678.78M$854.68M$1.05B$1.25B$1.41B$1.58B
Low Forecast$658.91M$837.73M$1.03B$1.23B$1.38B$1.58B
Surprise %-0.14%1.55%1.74%0.95%2.59%-

Net Income Forecast

$-350M $-270M $-190M $-110M $-30M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-307.20M$-215.56M$-186.26M$-57.44M$9.66M-
Avg Forecast$-319.77M$-222.68M$-175.90M$-61.60M$-54.26M$-7.77M
High Forecast$-313.82M$-219.71M$-170.23M$-60.24M$-30.90M$2.03M
Low Forecast$-326.18M$-225.50M$-181.58M$-62.97M$-65.24M$-17.57M
Surprise %-3.93%-3.20%5.89%-6.75%-117.81%-

LFST Forecast FAQ

Is LifeStance Health Group stock a buy?

LifeStance Health Group stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that LifeStance Health Group is a favorable investment for most analysts.

What is LifeStance Health Group's price target?

LifeStance Health Group's price target, set by 11 Wall Street analysts, averages $13.57 over the next 12 months. The price target range spans from $9 at the low end to $19 at the high end, suggesting a potential 6.02% change from the previous closing price of $12.8.

How does LifeStance Health Group stock forecast compare to its benchmarks?

LifeStance Health Group's stock forecast shows a 6.02% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (17.57%).

What is the breakdown of analyst ratings for LifeStance Health Group over the past three months?

  • September 2026: 18.18% Strong Buy, 63.64% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 18.18% Strong Buy, 63.64% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 18.18% Strong Buy, 63.64% Buy, 18.18% Hold, 0% Sell, 0% Strong Sell.

What is LifeStance Health Group’s EPS forecast?

LifeStance Health Group's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.02, marking a -166.67% decrease from the reported $0.03 in 2025..

What is LifeStance Health Group’s revenue forecast?

LifeStance Health Group's average annual revenue forecast for its fiscal year ending in December 2026 is $1.58B, reflecting a 11.12% increase from the reported $1.42B in 2025.

What is LifeStance Health Group’s net income forecast?

LifeStance Health Group's net income forecast for the fiscal year ending in December 2026 stands at $-7.77M, representing a -180.41% decrease from the reported $9.66M in 2025.